HOME › Press Releases › Pharmaceutical Packaging Market worth 94.93 Billion USD by 2021
Pharmaceutical Packaging Market worth 94.93 Billion USD by 2021
The report "Pharmaceutical Packaging Market by Type (Plastic Bottles, Blister Packs, Vials), Veterinary Vaccine Packaging (Livestock, Aquaculture, Porcine), Drug Delivery (Oral, Pulmonary, Topical), Raw Material (HDPE, LDPE), and Region - Global Forecast to 2021", The pharmaceutical packaging market was valued at USD 65.55 Billion in 2015 and is projected to reach USD 94.93 Billion by 2021, at a CAGR of 6.4% from 2016 to 2021.
Browse 94 market data tables and 44 figures spread through 189 pages and in-depth TOC on "Pharmaceutical Packaging Market by Type (Plastic Bottles, Blister Packs, Vials), Veterinary Vaccine Packaging (Livestock, Aquaculture, Porcine), Drug Delivery (Oral, Pulmonary, Topical), Raw Material (HDPE, LDPE), and Region - Global Forecast to 2021"
Early buyers will receive 10% customization on reports.
Growing urbanization across the globe, increasing affluence in the Asia-Pacific region, and rising demand for improved and efficient healthcare services, globally are the major drivers for the growth of the pharmaceutical packaging market. In addition to this, stringent government regulations related to manufacturing of counterfeit medicines in several countries of the world are also expected to fuel the growth of the pharmaceutical packaging market during the forecast period, 2016 to 2021.
Among types, the plastic bottles segment is projected to lead the pharmaceutical packaging market during the forecast period, 2016 to 2021.
Among types, the plastic bottles segment is projected to lead the pharmaceutical packaging market during the forecast period. Plastic bottles are the most preferred packaging used, globally. Factors, such as their easy availability and increased demand for administering oral drugs, prescription dose medicines, and over the counter (OTC) medicines are expected to drive the growth of the plastic bottles segment of pharmaceutical packaging market, globally between 2016 and 2021.
The injectables drug delivery segment of the pharmaceutical packaging market is projected to grow at the highest CAGR during the forecast period, 2016 to 2021.
The injectables drug delivery segment of the pharmaceutical packaging market is projected to grow at the highest CAGR from 2016 to 2021. Injectable drug delivery mode is receiving considerable attention due to efficiency offered by it in drug administration and high suitability of it for drug delivery in hospitals and other institutions. The R&D departments of different companies manufacturing pharmaceutical packaging are carrying out research & development activities to widen application areas of different types of pharmaceutical packaging, such as plastic bottles, blister packs, vials, and others through continuous innovations.
The Asia-Pacific pharmaceutical packaging market is projected to grow at the highest CAGR from 2016 to 2021.
The Asia-Pacific pharmaceutical packaging market possesses immense growth potential. Increasing demand for improved healthcare services, growing urbanization, and increasing affluence in the Asia-Pacific region are the factors expected to fuel the demand for pharmaceutical packaging during the forecast period. China, India, Japan, Australia, and South Korea are some of the key countries in the region that are significantly contributing towards the growth of the Asia-Pacific pharmaceutical packaging market.
Some of the key players in the pharmaceutical packaging market are Amcor Ltd. (Australia), Schott AG (Germany), AptarGroup, Inc. (U.S.), Gerresheimer AG (Germany), Becton, Dickinson and Company (U.S.), and Capsugel Inc. (U.S.), among others. Investments, expansions, and new product launches were the major growth strategies adopted by the market players between 2012 and 2016 to enhance their regional footprint and meet growing demand for pharmaceutical packaging in the emerging economies.
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India